MedPath
NMPA Approval

Carboprost Tromethamine Injection

国药准字H20249651

December 1, 2024

Drug Information

卡前列素氨丁三醇注射液

注射剂

1ml:250μg(按C₂₁H₃₆O₅计)

化学药品

December 1, 2024

Company Information

Applicant Company

北京市北京经济技术开发区融兴北一街21号院1号楼1层102室

Manufacturing Company

海南省海口市保税区A06-2

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

卡前列素氨丁三醇注射液 - NMPA 批准文号 | MedPath